A major news suddenly broke the tranquility of the night.

Everyone's mobile phones are crazily popping up headlines, all about the same thing.

"The State Administration of Drug Administration requires strict investigation into the cancer-causing problem of Sanofi antihypertensive drugs."

"Nitrosamine was detected in Sanofi's irbesartan drug and was ordered to recall the problematic drug."

"The Drug Administration's Iron Fist attacks, forcibly recalling the problematic drugs, or imposes a large fine."

Netizens were stunned when they looked at the news.

These days, they have been scolding foreign companies with double standards online.

Unexpectedly, the Drug Administration took action in such a short time and strongly dealt with the problem of double-standard drugs.

Suddenly, I felt relieved and proud.

When I opened the hot search, even the CCTV News official account issued a stern announcement.

"In response to the drug on sale worldwide by Sanofi, a pharmaceutical company in Gaul, and the nitrosamine problem of irbesartan tablets, the State Administration of Drug Administration attaches great importance to it and investigates Sanofi Huaxia Branch as soon as possible and deals with it in accordance with the law."

"The Beijing Drug Administration immediately organized personnel to conduct random inspections of the drugs on sale in Sanofi. After preliminary investigation and analysis, nitrosamine substances were detected in the Ambowei antihypertensive drugs sold by Sanofi, which was caused by the company's process problems during the production process."

"The State Administration of Drug Administration has dealt with this serious safety accident and asked Sanofi Huaxia Branch to recall the problematic batch of drugs immediately and handle relevant compensation and personnel litigation incidents in accordance with the law."

"After all drugs are recalled, an administrative fine of twenty times will be imposed based on the amount involved."

"Any pharmaceutical manufacturer in China must put product quality first and consciously abide by our country's laws and regulations and relevant technical specifications."

"Any product defects or quality problems must be taken to take recall measures, they must report to the drug regulatory authorities, and they must actively disclose information to the public. Any drug recalled abroad must be recalled simultaneously in China."

"The Drug Administration will further increase its supervision efforts, keep abreast of recall information from drug regulatory agencies in various countries, and do not report recalls of drug manufacturers and fail to promptly recall them. Strict regulatory measures will be taken until the production and sale of drugs in China are stopped."

Looking at this handling notice, netizens were shocked.

This is the first time that the State Administration of Drug Administration has made a tough statement to pharmaceutical companies in China.

People can see the official determination to strictly regulate drug safety.

There was a burst of murderous aura between the lines.

The netizens were speechless for a long time, and after a while, they cheered instantly.

"The General Administration is wise and has done a pretty job!"

"Retreat the problem medicine! Retreat! Retreat!"

"You are asked to double standards, and you will not recall it if you are stubborn. Now you will be suppressed by Iron Fist, hahaha!"

"Punishment! Punishment severely! Don't be polite, you must punish them until they hurt!"

"Are there any problems with other antihypertensive drugs? You have to check it."

"In the future, take Sanqing medicine, so don't worry."

"Support! We must investigate and punish severely according to law!"

"I just went to the official website of the Drug Administration. There have been many problematic drug recalls in the past year, most of which are domestic pharmaceutical companies. This time it's finally the turn of foreign companies."

"Since the last Changsheng vaccine accident, the pharmaceutical industry has still attached great importance to drug safety issues. Why, the official responded immediately."

"I hope other industries can follow up and clean up these dual-standard foreign companies. I remember the last time Menglong Ice Cream double-standard incident, and it seems that there is no follow-up."

"Then you have to contact the State Administration for Market Regulation. Maybe the double standard of ice cream is not serious. After all, it is just a fake ingredient list. It is not a human life if you eat it. It is definitely because no drugs cause cancer, which can attract more attention."

"Hey, I'm completely relieved about drug safety now. When can I take a heavy blow to food safety issues and make everyone feel more at ease?"

"It is hard to say that the domestic market environment will not learn from the lessons if there is no problem."

"If there is a problem, I won't learn from my experience. I'm still selling sauerkraut on my feet. I can only vote with my feet and I'll just refuse to buy it."

"That's right, whether it's medicine or food, you have to buy conscientious domestic products in the future. You must make foreign companies with double standards either cold or on the road of cold."

At the same time, Sanofi officially apologized to the entire network and announced the recall of the problematic batch of antihypertensive drugs.

"I'm sorry, I've let everyone down. We sincerely apologize to the Chinese people for the mistakes we have made."

"We will officially recall all problematic drugs sold in the Chinese market. After inspection, the problematic batches are xxxx and xxxx. Please return the patients who bought these batches of drugs immediately to the original hospital, and the payment will be returned as usual."

"From now on, we will be responsible for public health, carefully find the causes of the problem, improve quality management, implement various risk control measures, eliminate safety hazards, and ensure the quality of products on the market."

"If you have any questions, please do not hesitate and contact us as soon as possible to discuss the follow-up solutions. Thank you!"

This time Sanofi dared not turn off the comments anymore, and netizens flocked in to vent their emotions to the fullest.

"You are so stubborn that you can be harder than the people's iron fist?"

"I hope the official will be so tough in the future and suppress foreign companies with double standards."

"This wave of the drug administration bureau, @Marketing Administration, please take a look at how they do it!"

"Learn to learn, @Pfizer, @Johnson & Johnson, @Merck, @Roche, @Maple Leaf Goose, @Nike, @Two Stars, @Toyota, @Volkswagen, @IKEA, @Menglong."

Under this announcement, netizens @ed all foreign companies with dual standards.

I kept running to their official homepage to review.

For a moment, all foreign companies were frightened and trembling as they watched the situation.

While they were glad that they were not the ones sacrificed to heaven, they wailed in their hearts.

Is the Chinese market going to change?

Is this the official killing the chicken to warn the monkey?

Will there be severe investigations in the future if there is any problem?

When I thought of this, all the executives in the Huaxia District of foreign companies felt a chill on their necks and gusts of cold wind blew.

After Sanofi was established as a typical example, the drug supervision bureaus of all cities began to increase efforts to randomly check drugs on sale and detect drug quality problems.

Other pharmaceutical companies have also responded to strengthen the quality control of their own drugs.

For a moment, the news of the wind and the imports of the entire antihypertensive drug market dropped sharply.

Under such circumstances, Sanqingxin’s antihypertensive drugs were almost pushed in by a strong force, instantly filling the market that suddenly fell into a vacuum.

The Drug Administration also figured it out through Sanofi.

It is probably more difficult to rely solely on pharmaceutical companies to declare problems consciously and recall them voluntarily. It is still necessary to rely on strengthening supervision and severe punishment to truly play a role like the Eagle Country.

Generally speaking, after adverse reactions occur in drugs, companies should evaluate them for safety, choose to add black boxes to warn risks, or restrict the use of the population. If the risk of the drug exceeds the benefits, it needs to be recalled.

Recalls must also be different in different situations. If there is a problem with the drug formula or medical device, or the product itself has defects, then all products must be recalled.

If there is a non-systematic quality problem in a certain production or transportation process, then you only need to recall the batch of products.

Due to the wide variety of drugs, it is impossible for regulatory authorities to fully grasp the adverse reactions of all drugs as soon as possible. They mainly rely on the company's active reporting.

Monitoring of adverse drug reactions is the upstream link of drug recall, and it should play a major role in theory.

Drug recall is the last firewall for drug safety.

In Yingguo, 60% of adverse drug reaction reports are reported by companies on their own initiative, but in China, the opposite is true.

The proportion of drug adverse reaction test reports by domestic pharmaceutical companies is only 25%.

If the adverse drug reaction information cannot be reported in time, then the subsequent drug recall process will inevitably be absent.

To ensure drug safety, not only does it require strengthening supervision, but the company itself must also be able to correctly handle the relationship between the interests of the company and the interests of patients.

After this incident, drug safety issues have once again attracted the attention of decision-makers.

The thunder of the Drug Administration this time undoubtedly revealed their attitude and determination.


Chapter completed!